Petros Pharmaceuticals Inc (PTPI) Up 1.27% in Premarket Trading

Petros Pharmaceuticals Inc (PTPI) has gained Tuesday morning, with the stock rising 1.27% in pre-market trading to 1.59. PTPI's short-term technical score of 47 indicates that the stock has traded less bullishly over the last month than 53% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 96 out of 146 industries, PTPI ranks higher than 59% of stocks. Petros Pharmaceuticals Inc has fallen 4.85% over the past month, closing at $1.66 on February 27. During this period of time, the stock fell as low as $1.38 and as high as $1.76. PTPI has an average analyst recommendation of Strong Buy. The company has an average price target of $4.00.

PTPI has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on PTPI!

See Full PTPI Report

Petros Pharmaceuticals Inc has a Long-Term Technical rank of 59. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 41% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 87 by this metric, PTPI ranks better than 87% of stocks.

Important Dates for Investors in PTPI:

-Petros Pharmaceuticals Inc is set to release earnings on 2024-03-27. Over the last 12 months, the company has reported EPS of $-6.21. -We do not have a set dividend date for Petros Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Petros Pharmaceuticals Inc (PTPI)